Clinical Trial

Balance Confidence and Kinesiophobia in Parkinson's Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated January 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
31 patients aged 50-80 years diagnosed with idiopathic Parkinson's disease (Modified Hoehn-Yahr stages 1-3) and 31 healthy volunteers. At the start of the study, sociodemographic data for all participants will be recorded. To assess the mental and functional status of Parkinson's disease patients, the Mini-Mental State Examination (MMSE) and the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) will be used. Balance confidence levels will be assessed using the Activities-specific Balance Confidence Scale-6 (ABC-6), overall balance using the Berg Balance Scale (BBS), fear of falling using the Falls Efficacy Scale (FES), and kinesiophobia levels using the Tampa Scale of Kinesiophobia (TSK).
Trial Details
NCT Number NCT06751797
Lead Sponsor Beylikduzu State Hospital
Conditions Parkinson Disease
Enrollment 62 participants
Start Date 2024-12-10
Primary Completion 2025-01-20 (estimated)
Study Completion 2025-01-20 (estimated)
Updated on ClinicalTrials.gov 2024-12-30